Cui Yazhou, Zhou Xiaoyan, Han Jinxiang
Shandong Academy of Medical Science, Shandong Medical Biotechnological Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Jinan 250062, China.
Orphanet J Rare Dis. 2014 Jan 27;9:14. doi: 10.1186/1750-1172-9-14.
China is facing the great challenge of serving the world's largest rare disease population. It is necessary to develop a specific medical plan to increase the levels of optimal prevention, diagnosis and treatment of rare diseases under the existing clinical service structures in China. In 2013, China launched its first pilot project focused on 20 representative rare diseases. A national network including approximately 100 provincial or municipal medical centers has been established to enable collaboration on rare diseases across China. The main objectives for this project are to develop and apply medical guidelines and clinical pathways for rare diseases, to establish a rare disease patient registry and data repository system, and to promote molecular testing for rare genetic disorders. This project also emphasizes building close links among the collaborative network, clinicians on the frontlines in basic medical services institutions and rare disease patient organizations. Primarily, this project expects to develop an actionable medical services plan to increase the delivery of quality healthcare for individuals and families living with rare diseases in China within five years.
中国正面临着为全球最大的罕见病患者群体提供服务的巨大挑战。有必要制定一项专门的医疗计划,以在现有临床服务体系下提高中国罕见病的最佳预防、诊断和治疗水平。2013年,中国启动了首个针对20种具有代表性的罕见病的试点项目。一个包括约100家省级或市级医疗中心的全国性网络已建立起来,以便在中国各地开展罕见病方面的合作。该项目的主要目标是制定并应用罕见病医疗指南和临床路径,建立罕见病患者登记和数据存储系统,并推广罕见遗传性疾病的分子检测。该项目还强调在协作网络、基层医疗服务机构的一线临床医生和罕见病患者组织之间建立紧密联系。该项目主要期望在五年内制定一项可实施的医疗服务计划,以增加为中国罕见病患者及其家庭提供的优质医疗服务。